Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. Cash on Hand 2008–2025
Regeneron Pharmaceuticals, Inc. annual cash on hand history from 2009 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Regeneron Pharmaceuticals, Inc. cash on hand as of December 31, 2025: 3.12B, a 25.32% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. cash on hand for 2025 were 3.12B, a 25.32% increase from 2024.
- Regeneron Pharmaceuticals, Inc. cash on hand for 2024 were 2.49B, a 8.86% decrease from 2023.
- Regeneron Pharmaceuticals, Inc. cash on hand for 2023 were 2.73B, a 12.10% decrease from 2022.
- Regeneron Pharmaceuticals, Inc. cash on hand for 2022 were 3.11B.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Regeneron Pharmaceuticals, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $3,118 |
| 2024 | $2,488 |
| 2023 | $2,730 |
| 2022 | $3,106 |
| 2021 | $2,886 |
| 2020 | $2,194 |
| 2019 | $1,618 |
| 2018 | $1,468 |
| 2017 | $813 |
| 2016 | $535 |
| 2015 | $809 |
| 2014 | $649 |
| 2013 | $536 |
| 2012 | $230 |
| 2011 | $484 |
Regeneron Pharmaceuticals Inc. Cash on Hand — FAQ
Regeneron Pharmaceuticals Inc. (REGN) cash on hand over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REGN's cash on hand history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s cash on hand by year and by quarter, including the growth rate.